JNCI Monographs

Jeffrey S. Abrams and Patricia Eifel

Monograph Overview
J Natl Cancer Inst Monogr 2001 2001: 1. [Full Text] [PDF]  

National Institutes of Health Consensus Development Panel

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1–3, 2000
J Natl Cancer Inst Monogr 2001 2001: 5. [Abstract] [Full Text] [PDF]  

William C. Wood

Adjuvant Therapy for Breast Cancer: Current Controversies and Future Prospects
J Natl Cancer Inst Monogr 2001 2001: 16. [Full Text] [PDF]  

Gary M. Clark

Interpreting and Integrating Risk Factors for Patients With Primary Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 17. [Abstract] [Full Text] [PDF]  

Stuart J. Schnitt

Traditional and Newer Pathologic Factors
J Natl Cancer Inst Monogr 2001 2001: 22. [Abstract] [Full Text] [PDF]  

Maria Grazia Daidone and Rosella Silvestrini

Prognostic and Predictive Role of Proliferation Indices in Adjuvant Therapy of Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 27. [Abstract] [Full Text] [PDF]  

James J. Dignam

Efficacy of Systemic Adjuvant Therapy for Breast Cancer in African-American and Caucasian Women
J Natl Cancer Inst Monogr 2001 2001: 36. [Abstract] [Full Text] [PDF]  

Aron Goldhirsch, Richard D. Gelber, Greg Yothers, Robert J. Gray, Stephanie Green, John Bryant, Shari Gelber, Monica Castiglione-Gertsch, and Alan S. Coates

Adjuvant Therapy for Very Young Women With Breast Cancer: Need for Tailored Treatments
J Natl Cancer Inst Monogr 2001 2001: 44. [Abstract] [Full Text] [PDF]  

Hyman B. Muss

Factors Used to Select Adjuvant Therapy of Breast Cancer in the United States: an Overview of Age, Race, and Socioeconomic Status
J Natl Cancer Inst Monogr 2001 2001: 52. [Abstract] [Full Text] [PDF]  

John Bryant, Bernard Fisher, and James Dignam

Duration of Adjuvant Tamoxifen Therapy
J Natl Cancer Inst Monogr 2001 2001: 56. [Abstract] [Full Text] [PDF]  

Bernard Fisher, Jong-Hyeon Jeong, James Dignam, Stewart Anderson, Eleftherios Mamounas, D. Lawrence Wickerham, and Norman Wolmark

Findings From Recent National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies in Stage I Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 62. [Abstract] [Full Text] [PDF]  

Nancy E. Davidson

Ovarian Ablation as Adjuvant Therapy for Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 67. [Full Text] [PDF]  

Gabriel N Hortobagyi

Progress in Systemic Chemotherapy of Primary Breast Cancer: an Overview
J Natl Cancer Inst Monogr 2001 2001: 72. [Abstract] [Full Text] [PDF]  

Peter Marcus Ravdin

Is Her2 of Value in Identifying Patients Who Particularly Benefit From Anthracyclines During Adjuvant Therapy? A Qualified Yes.
J Natl Cancer Inst Monogr 2001 2001: 80. [Abstract] [Full Text] [PDF]  

George W. Sledge, Jr.

Is HER-2/neu a Predictor of Anthracycline Utility? No.
J Natl Cancer Inst Monogr 2001 2001: 85. [Abstract] [Full Text] [PDF]  

Martine J Piccart, Caroline Lohrisch, Luc Duchateau, and Marc Buyse

Taxanes in the Adjuvant Treatment of Breast Cancer: Why Not Yet?
J Natl Cancer Inst Monogr 2001 2001: 88. [Abstract] [Full Text] [PDF]  

Norman Wolmark, Jiping Wang, Eleftherios Mamounas, John Bryant, and Bernard Fisher

Preoperative Chemotherapy in Patients With Operable Breast Cancer: Nine-Year Results From National Surgical Adjuvant Breast and Bowel Project B-18
J Natl Cancer Inst Monogr 2001 2001: 96. [Abstract] [Full Text] [PDF]  

Jonas Bergh and Marit Holmquist

Who Should Not Receive Adjuvant Chemotherapy? International Databases
J Natl Cancer Inst Monogr 2001 2001: 103. [Abstract] [Full Text] [PDF]  

Monica Morrow and Helen Krontiras

Who Should Not Receive Chemotherapy? Data From American Databases and Trials
J Natl Cancer Inst Monogr 2001 2001: 109. [Abstract] [Full Text] [PDF]  

Karen H. Antman

Overview of the Six Available Randomized Trials of High-Dose Chemotherapy With Blood or Marrow Transplant in Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 114. [Full Text] [PDF]  

Lori J. Pierce

Treatment Guidelines and Techniques in Delivery of Postmastectomy Radiotherapy in Management of Operable Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 117. [Abstract] [Full Text] [PDF]  

Amy S. Langer

Side Effects, Quality-of-Life Issues, and Trade-offs: the Patient Perspective
J Natl Cancer Inst Monogr 2001 2001: 125. [Abstract] [Full Text] [PDF]  

Patricia A. Ganz

Impact of Tamoxifen Adjuvant Therapy on Symptoms, Functioning, and Quality of Life
J Natl Cancer Inst Monogr 2001 2001: 130. [Abstract] [Full Text] [PDF]  

Ann H. Partridge, Harold J. Burstein, and Eric P. Winer

Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Early-Stage Breast Cancer
J Natl Cancer Inst Monogr 2001 2001: 135. [Abstract] [Full Text] [PDF]  

Mark Levine and Tim Whelan

Decision-Making Process—Communicating Risk/Benefits: Is There an Ideal Technique?
J Natl Cancer Inst Monogr 2001 2001: 143. [Full Text] [PDF]  

R. John Simes and Alan S. Coates

Patient Preferences for Adjuvant Chemotherapy of Early Breast Cancer: How Much Benefit Is Needed?
J Natl Cancer Inst Monogr 2001 2001: 146. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.